Heart drug may ease arthritis pain in new trial
NCT ID NCT07516769
First seen Apr 26, 2026 · Last updated May 03, 2026 · Updated 2 times
Summary
This study tests whether nicorandil, a heart medication, can reduce inflammation and improve symptoms in people with active rheumatoid arthritis. About 46 adults who are already taking standard arthritis drugs will receive nicorandil or a placebo for 3 months. Researchers will measure joint swelling, pain, and quality of life to see if the drug helps control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHUMATOID ARTHISIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tanta university
RECRUITINGTanta, Gharbia Governorate, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.